26
20
Brain Tumor Reports

Volume 10 Number 3
March 2010

Home > Publications > Brain Tumor Reports > Volume 10, Year 2010 > Number 3, March°


Contents



Classification



Verhaak RG, Hoadley KA, Purdom E, Wang V, Qi Y, Wilkerson MD, Miller CR, Ding L, Golub T, Mesirov JP, Alexe G, Lawrence M, O'Kelly M, Tamayo P, Weir BA, Gabriel S, Winckler W, Gupta S, Jakkula L, Feiler HS, Hodgson JG, James CD, Sarkaria JN, Brennan C, Kahn A, Spellman PT, Wilson RK, Speed TP, Gray JW, Meyerson M, Getz G, Perou CM, Hayes DN.
Integrated Genomic Analysis Identifies Clinically Relevant Subtypes of Glioblastoma Characterized by Abnormalities in PDGFRA, IDH1, EGFR, and NF1.
Cancer Cell. 2010 Jan 19;17(1):98-110.
 
Abstract |   Reprint |   Related articles


Diagnosis



Kano H, Kondziolka D, Lobato-Polo J, Zorro O, Flickinger JC, Lunsford LD
T1/T2 matching to differentiate tumor growth from radiation effects after stereotactic radiosurgery
Neurosurgery. 2010 Mar;66(3):486-92.
  Abstract

Winterstein M, Münter MW, Burkholder I, Essig M, Kauczor HU, Weber MA
Partially Resected Gliomas: Diagnostic Performance of Fluid-attenuated Inversion Recovery MR Imaging for Detection of Progression
Radiology. 2010 Feb 1. [Epub ahead of print]
  Abstract


Etiology & Pathogenesis



Christmann M, Nagel G, Horn S, Krahn U, Wiewrodt D, Sommer C, Kaina B
MGMT activity, promoter methylation and immunohistochemistry of pre-treatment and recurrent malignant gliomas: A comparative study on astrocytoma and glioblastoma
Int J Cancer. 2010 Feb 3;. [Epub ahead of print]
  Abstract

Gadji M, Fortin D, Tsanaclis AM, Garini Y, Katzir N, Wienburg Y, Yan J, Klewes L, Klonisch T, Drouin R, Mai S
Three-dimensional Nuclear Telomere Architecture Is Associated with Differential Time to Progression and Overall Survival in Glioblastoma Patients
Neoplasia. 2010 Feb;12(2):183-91
  Abstract |   Full Text |   Reprint

Kyritsis AP, Bondy ML, Rao JS, Sioka C
Inherited predisposition to glioma
Neuro Oncol. 2010 Jan;12(1):104-13
  Abstract

Lehrer S
Glioblastoma and dementia may share a common cause
Med Hypotheses. 2010 Feb 22;. [Epub ahead of print]
  Abstract


Integrative Medicine



Dwarakanath BS, Huilgol NG
Tumors show enhanced dependency on glucose and glycolytic pathway
J Cancer Res Ther. 2009 Sep;5 Suppl 1:S1. Epub 2009 Aug 21
  Abstract |   Full Text

Kang SS, Han KS, Ku BM, Lee YK, Hong J, Shin HY, Almonte AG, Woo DH, Brat DJ, Hwang EM, Yoo SH, Chung CK, Park SH, Paek SH, Roh EJ, Lee SJ, Park JY, Traynelis SF, Lee CJ
Caffeine-mediated inhibition of calcium release channel inositol 1,4,5-trisphosphate receptor subtype 3 blocks glioblastoma invasion and extends survival
Cancer Res. 2010 Feb 1;70(3):1173-83. Epub 2010 Jan 26
  Abstract

Mazzini F, Betti M, Canonico B, Netscher T, Luchetti F, Papa S, Galli F.
Anticancer Activity of Vitamin E-Derived Compounds in Murine C6 Glioma Cells
ChemMedChem. 2010 Feb 4;. [Epub ahead of print]
  Abstract

Seyfried BT, Kiebish M, Marsh J, Mukherjee P
Targeting energy metabolism in brain cancer through calorie restriction and the ketogenic diet
J Cancer Res Ther. 2009 Sep;5 Suppl 1:S7-15. Epub 2009 Aug 21
  Abstract |   Full Text


Overall Management



Knox MK, Ménard C, Mason WP
Leptomeningeal gliomatosis as the initial presentation of gliomatosis cerebri
J Neurooncol. 2010 Feb 10. [Epub ahead of print]
  Abstract |   Full Text |   Reprint

Meyzer C, Dhermain F, Ducreux D, Habrand JL, Varlet P, Sainte-Rose C, Dufour C, Grill J
A case report of pseudoprogression followed by complete remission after proton-beam irradiation for a low-grade glioma in a teenager: the value of dynamic contrast-enhanced MRI
Radiat Oncol. 2010 Feb 4;5(1):9. [Epub ahead of print]
  Abstract |   Full Text |   Reprint

Noshita N, Mashiyama S, Fukawa O, Asano S, Watanabe M, Tominaga T
Extracranial metastasis of anaplastic oligodendroglioma with 1p19q loss of heterozygosity
Neurol Med Chir (Tokyo). 2010;50(2):161-4
  Abstract |   Reprint

Polley MY, Lamborn KR, Chang SM, Butowski N, Clarke JL, Prados M
Six-month progression-free survival as an alternative primary efficacy endpoint to overall survival in newly diagnosed glioblastoma patients receiving temozolomide
Neuro Oncol. 2010 Mar;12(3):274-82. Epub 2009 dec 21
  Abstract

Showalter TN, Lin A
Aggressive Trimodality Therapy for T1N2M1 Nonsmall Cell Lung Cancer with Synchronous Solitary Brain Metastasis: Case Report and Rationale
Case Report Med. 2009;2009:276571
  Abstract |   Full Text |   Reprint

Stavrinou P, Magras I, Stavrinou LC, Zaraboukas T, Polyzoidis KS, Selviaridis P
Primary extracerebral meningeal glioblastoma: clinical and pathological analysis
Cen Eur Neurosurg. 2010 Feb;71(1):46-9. Epub 2010 Feb 19.
  Abstract

Warnke PC
A 31-year-old woman with a transformed low-grade glioma
JAMA. 2010 Mar 10;303(10):967-76. Epub 2010 Feb 16
  Abstract |   Full Text |   Reprint

Yan DF, Yan SX, Yang JS, Wang YX, Sun XL, Liao XB, Liu JQ
Hemorrhage of brain metastasis from non-small cell lung cancer post gefitinib therapy: two case reports and review of the literature
BMC Cancer. 2010 Feb 21;10(1):49. [Epub ahead of print]
  Abstract |   Full Text |   Reprint

Zhang L, Li F, Zhang Y, Zhu S
A rare paraganglioma with skull and brain metastasis
J Clin Neurosci. 2010 Feb 24;. [Epub ahead of print]
  Abstract


Prognosis



Antonelli M, Buttarelli FR, Arcella A, Nobusawa S, Donofrio V, Oghaki H, Giangaspero F
Prognostic significance of histological grading, p53 status, YKL-40 expression, and IDH1 mutations in pediatric high-grade gliomas
J Neurooncol. 2010 Feb 21;. [Epub ahead of print]
  Abstract |   Full Text |   Reprint

Inoue R, Takahashi A, Takasugi S, Masumori N, Tsukamoto T, Hasegawa T
Prognostic factors in patients with metastatic renal cell carcinoma
Hinyokika Kiyo. 2010 Feb;56(2):75-9
  Abstract

Mazloom A, Zangeneh AH, Paulino AC
Prognostic Factors after Extraneural Metastasis of Medulloblastoma
Int J Radiat Oncol Biol Phys. 2010 Feb 2. [Epub ahead of print]
  Abstract


Psychosocial Aspects



Curry WT Jr, Carter BS, Barker FG 2nd
Racial, Ethnic, and Socioeconomic Disparities in Patient Outcomes after Craniotomy for Tumor in Adult Patients in the United States, 1988-2004
Neurosurgery. 2010 Jan 28;. [Epub ahead of print]
  Abstract

Cherny NI, Baselga J, de Conno F, Radbruch L
Formulary availability and regulatory barriers to accessibility of opioids for cancer pain in Europe: a report from the ESMO/EAPC Opioid Policy Initiative
Ann Oncol. 2010 Mar;21(3):615-26
  Abstract |   Full Text |   Reprint

Cleary JF, Hutson P, Joranson D
Access to therapeutic opioid medications in Europe by 2011? Fifty years on from the Single Convention on Narcotic Drugs
Palliat Med. 2010 Mar;24(2):109-10. Epub 2010 Feb 22
  Abstract |   Reprint


Stem Cells



Bikeye SN, Colin C, Marie Y, Vampouille R, Ravassard P, Rousseau A, Boisselier B, Idbaih A, Calvo CF, Leuraud P, Lassalle M, El Hallani S, Delattre JY, Sanson M
ASPM-associated stem cell proliferation is involved in malignant progression of gliomas and constitutes an attractive therapeutic target
Cancer Cell Int. 2010 Jan 11;10:1
  Abstract |   Full Text |   Reprint

Charles N, Ozawa T, Squatrito M, Bleau AM, Brennan CW, Hambardzumyan D, Holland EC
Perivascular Nitric Oxide Activates Notch Signaling and Promotes Stem-like Character in PDGF-Induced Glioma Cells
Cell Stem Cell. 2010 Feb 5;6(2):141-152
  Abstract

Clément V, Marino D, Cudalbu C, Hamou MF, Mlynarik V, de Tribolet N, Dietrich PY, Gruetter R, Hegi ME, Radovanovic I
Marker-independent identification of glioma-initiating cells
Nat Methods. 2010 Mar;7(3):224-8. Epub 2010 Feb 21
  Abstract

Hjelmeland AB, Wu Q, Wickman S, Eyler C, Heddleston J, Shi Q, Lathia JD, Macswords J, Lee J, McLendon RE, Rich JN.
Targeting a20 decreases glioma stem cell survival and tumor growth
PLoS Biol. 2010 Feb 23;8(2):e1000319
  Abstract |   Full Text |   Reprint

Lottaz C, Beier D, Meyer K, Kumar P, Hermann A, Schwarz J, Junker M, Oefner PJ, Bogdahn U, Wischhusen J, Spang R, Storch A, Beier CP
Transcriptional Profiles of CD133+ and CD133- Glioblastoma-Derived Cancer Stem Cell Lines Suggest Different Cells of Origin
Cancer Res. 2010 Feb 9;. [Epub ahead of print]
  Abstract

Mercapide J, Rappa G, Anzanello F, King J, Fodstad O, Lorico A
Primary gene-engineered neural stem/progenitor cells demonstrate tumor-selective migration and antitumor effects in glioma
Int J Cancer. 2010 Mar 1;126(5):1206-15. Epub 2009 Aug 3
  Abstract |   Full Text |   Reprint

Sato A, Sakurada K, Kumabe T, Sasajima T, Beppu T, Asano K, Ohkuma H, Ogawa A, Mizoi K, Tominaga T, Kitanaka C, Kayama T
Association of stem cell marker CD133 expression with dissemination of glioblastomas
Neurosurg Rev. 2010 Apr;33(2):175-83; Epub 2010 Feb 5.
  Abstract

Zhao Y, Wang S
Human NT2 Neural Precursor-Derived Tumor-Infiltrating Cells as Delivery Vehicles for Treatment of Glioblastoma
Hum Gene Ther. 2010 Jan 29;. [Epub ahead of print]
  Abstract


Treatment


Clinical Investigations


Brandes AA, Franceschi E, Tosoni A, Bartolini S, Bacci A, Agati R, Ghimenton C, Turazzi S, Talacchi A, Skrap M, Marucci G, Volpin L, Morandi L, Pizzolitto S, Gardiman M, Andreoli A, Calbucci F, Ermani M
O(6)-methylguanine DNA-methyltransferase methylation status can change between first surgery for newly diagnosed glioblastoma and second surgery for recurrence: clinical implications
Neuro Oncol. 2010 Mar;12(3):283-8
  Abstract

Casanova N, Mazouni Z, Bieri S, Combescure C, Pica A, Weber DC
Whole brain radiotherapy with a conformational external beam radiation boost for lung cancer patients with 1-3 brain metastasis: a multi institutional study
Radiat Oncol. 2010 Feb 18;5(1):13. [Epub ahead of print]
  Abstract |   Full Text |   Reprint

Galanis E, Buckner JC.
Enzastaurin in the Treatment of Recurrent Glioblastoma: A Promise That Did Not Materialize
J Clin Oncol. 2010 Feb 1. [Epub ahead of print]
  Abstract |   Reprint

Heute D, Kostron H, von Guggenberg E, Ingorokva S, Gabriel M, Dobrozemsky G, Stockhammer G, Virgolini IJ
Response of recurrent high-grade glioma to treatment with (90)Y-DOTATOC
J Nucl Med. 2010 Mar;51(3):397-400. Epub 2010 Feb 11
  Abstract

Iwamoto FM, Kreisl TN, Kim L, Duic JP, Butman JA, Albert PS, Fine HA
Phase 2 trial of talampanel, a glutamate receptor inhibitor, for adults with recurrent malignant gliomas
Cancer. 2010 Feb 8;. [Epub ahead of print]
  Abstract

Jang WY, Lee KS, Son BC, Jeun SS, Hong YK, Lee SW, Yang SH
Repeat Operations in Pediatric Patients with Recurrent Craniopharyngiomas
Pediatr Neurosurg. 2010 Jan 26;45(6):451-455. [Epub ahead of print]
  Abstract |   Full Text |   Reprint

Kong DS, Lee JI, Im YS, Nam DH, Park K, Kim JH
Differential Impact of Whole-Brain Radiotherapy Added to Radiosurgery for Brain Metastases
Int J Radiat Oncol Biol Phys. 2010 Jan 22. [Epub ahead of print]
  Abstract

Massimino M, Spreafico F, Riva D, Biassoni V, Poggi G, Solero C, Gandola L, Genitori L, Modena P, Simonetti F, Potepan P, Casanova M, Meazza C, Clerici CA, Catania S, Sardi I, Giangaspero F
A lower-dose, lower-toxicity cisplatin-etoposide regimen for childhood progressive low-grade glioma
J Neurooncol. 2010 Feb 12. [Epub ahead of print]
  Abstract |   Full Text |   Reprint

Massimino M, Cohen KJ, Finlay JL.
Is there a role for myeloablative chemotherapy with autologous hematopoietic cell rescue in the management of childhood high-grade astrocytomas?
Pediatr Blood Cancer. 2010 Feb 9;54(4):641-643. [Epub ahead of print]
  Abstract

Recinos VR, Tyler BM Ba, Bekelis K, Sunshine SB Bs, Vellimana A, Li KW, Brem H
Combination of Intracranial Temozolomide With Intracranial Carmustine Improves Survival When Compared With Either Treatment Alone in a Rodent Glioma Model
Neurosurgery. 2010 Mar;66(3):530-537
  Abstract

Reithmeier T, Graf E, Piroth T, Trippel M, Pinsker MO, Nikkhah G
BCNU for recurrent glioblastoma multiforme: efficacy, toxicity and prognostic factors
BMC Cancer. 2010 Feb 2;10(1):30. [Epub ahead of print]
  Abstract |   Full Text |   Reprint

Rolle K, Nowak S, Wyszko E, Nowak M, Zukiel R, Piestrzeniewicz R, Gawronska I, Barciszewska MZ, Barciszewski J
Promising human brain tumors therapy with interference RNA intervention (iRNAi)
Cancer Biol Ther. 2010 Mar 16;9(5). [Epub ahead of print]
  Abstract

Sanai N and S. Berger MS
Intraoperative stimulation techniques for functional pathway preservation and glioma resection
Neurosurg Focus. 2010 Feb;28(2):E1. Posted online on 1 Feb 2010
  Abstract |   Full Text |   Reprint

Sanghera P, Perry J, Sahgal A, Symons S, Aviv R, Morrison M, Lam K, Davey P, Tsao MN
Pseudoprogression following chemoradiotherapy for glioblastoma multiforme
Can J Neurol Sci. 2010 Jan;37(1):36-42
  Abstract

Szelényi A, Bello L, Duffau H, Fava E, Feigl GC, Galanda M, Neuloh G, Signorelli F, Sala F
Intraoperative electrical stimulation in awake craniotomy: methodological aspects of current practice
Neurosurg Focus. 2010 Feb;28(2):E7. Posted online on 1 Feb 2010
  Abstract |   Full Text |   Reprint

Wick W, Weller M, van den Bent M, Stupp R
Bevacizumab and Recurrent Malignant Gliomas: A European Perspective
J Clin Oncol. 2010 Mar 8. [Epub ahead of print]
  Abstract |   Reprint

Wick W, Puduvalli VK, Chamberlain MC, van den Bent MJ, Carpentier AF, Cher LM, Mason W, Weller M, Hong S, Musib L, Liepa AM, Thornton DE, Fine HA
Phase III Study of Enzastaurin Compared With Lomustine in the Treatment of Recurrent Intracranial Glioblastoma
J Clin Oncol. 2010 Feb 1. [Epub ahead of print]
  Abstract

Zuniga RM, Torcuator R, Jain R, Anderson J, Doyle T, Schultz L, Mikkelsen T
Rebound tumour progression after the cessation of bevacizumab therapy in patients with recurrent high-grade glioma
J Neurooncol. 2010 Sep;99(2):237-42. Epub 2010 Feb 12.
 
Abstract |   Reprint |   Related articles


Patients & Caregivers



Strangman D, Oliver K
IBTA E-News
International Brain Tumour Alliance,
12 February 2010